Marseille, France

Yi Xia

This inventor holds 1 USPTO granted patent. Top assignees: Centre National De La Recherche Scientifique, National Institute of Health and Medical Research. Active years: 2013.


Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yi Xia: Innovator in Therapeutics

Introduction

Yi Xia is a notable inventor based in Marseilles, France. He has made significant contributions to the field of therapeutics, particularly in the development of novel compounds for cancer treatment. His work exemplifies the intersection of innovation and medical research.

Latest Patents

Yi Xia holds a patent for "Triazole derivatives, their preparation and their application in therapeutics." This invention relates to novel compounds of a specific formula, which are designed for therapeutic applications, especially in the treatment of cancers. The patent outlines the processes for preparing these compounds and their potential uses in medical treatments.

Career Highlights

Throughout his career, Yi Xia has been associated with prestigious research institutions. He has worked at the Institut National de la Santé et de la Recherche Médicale and the Centre National de la Recherche Scientifique. His roles in these organizations have allowed him to contribute to significant advancements in medical research and innovation.

Collaborations

Yi Xia has collaborated with notable colleagues, including Ling Peng and Palma Rocchi. These partnerships have fostered a collaborative environment that enhances the research and development of therapeutic solutions.

Conclusion

Yi Xia's contributions to the field of therapeutics through his innovative patents and collaborations highlight his role as a key figure in medical research. His work continues to impact the development of treatments for serious health conditions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…